By Griffin Basden, Senior Client Manager at AlphaRoot
Once the fields are cut and the curing rooms are filled, the race to secure passing Certificates of Analysis (COAs) is on. As any cultivator knows, a passing COA is the last step between the curing room and product on shelves.
But a passing lab test is far from a permanent guarantee. In February this year, New York’s Office of Cannabis Management recalled products from Keystone State Testing after discovering 54 lots had misreported a passing for Aspergillus. And, in November 2025, Colorado regulators recalled a harvest batch from an outdoor grow in Ordway after failures to test for mold and yeast. That flower had already been sold at over twenty dispensaries.
This precedent makes evident a gap between initial clearance and market safety.
Compliance itself is not indemnification. Whereas a state-mandated test grants legal permission to distribute, the financial burden will inevitably fall squarely on the brand and not the laboratory when regulators intervene. In other words, the brand ends up paying for when something goes sideways.
Lab Shopping and Inaccurate Data Are Broken Incentives
Testing labs are, quite simply, commercial businesses competing for cultivators’ money, and they’re incentivized by speed, high THC numbers and low failure rates.
The MCR Labs litigation, where alleging competitors systematically inflated THC numbers and ignored microbial safety failures, revealed widespread discrepancies in state testing data, which have in turn created exposures for operators relying on these results to go to market.
And yet the threat is far from being purely microbial. Regulators are actively widening tests to include banned extraction solvents like methylene chloride and unapproved converted cannabinoids. This recalculation has caught operators off guard when state re-testing protocols differ from initial lab methods.
Here, when tests must be re-run, or when a non-compliant product is pulled from the shelves, the brand is left holding the bag once again.
Why the Testing Lab Rarely Shares the Cost
When a state regulator orders a recall, the operator faces hundreds of thousands in wiped inventory, logistics costs, and dispensary chargebacks.
The lab isn’t the one to pay because the contract says so; the standard commercial lab Master Services Agreement (MSA) usually limits the testing facility’s liability to the cost of the test itself. In practice, this looks like refunding a $400 testing fee on a $200,000 crop loss, for example.
And on the insurance side, if a brand isn’t working with a cannabis-specific broker, policies may still fall short of covering the financial loss. Standard Commercial General Liability (CGL) policies only trigger on third-party bodily injury or property damage, not on product recall or regulatory seizure, meaning that without a dedicated and custom-tailored Product Recall and Contaminated Products coverage, an operator again ends up absorbing 100% of the financial shock.
The Operator’s Self-Defense Strategy
Though the losses can feel inevitable, they most certainly are not. Cannabis operators can still take action to protect their business and their bottom line from the potential financial fallout of a costly recall.
1. Demand Contractual Accountability
Boilerplate MSAs do little to support an operator’s business interests. Operators should negotiate meaningful liability floors or carve-outs for methodological errors and data misreporting, while also requiring testing labs to provide Certificates of Insurance showing active Professional Liability policies that protect their customers.
2. Implement Pre-Compliance Blind Testing
Prior to submitting official harvest manifests into state tracking systems like Metrc, operators can run blind and split-sample tests across multiple accredited labs. It is only when inconsistencies are discovered early that cultivators can remediate, re-cure or redirect flower to extraction before a public recall hits both the state wire and their bank account.
Evidently, it’s a matter of preserving both credibility and business operations.
3. Audit Co-Packers and Input Suppliers
For processed products including edibles, tinctures, concentrates and vapes, operators can, and should, require labs to provide full chain-of-custody documentation and solvent screening warranties from contract extractors and distillate brokers. Any discrepancy can shift recall liability back to the lab or its contractors instead of their brand.
Staying Ahead of the Next Recall
Clean compliance can cost a brand its reputation, its business operations, and its relationship with dispensaries, on top of fines. The best time to look ahead and negotiate a lab contract or to check coverage is before the harvest or at a contractual renewal. Otherwise, operators might be empty-handed when the recall notice arrives.
And while it may seem counterintuitive to pay for split-sample testing or recall coverage, with many operators believing their current measures protect them “enough,” they cost a fraction of what a recall can do to a business. So, budgeting them as a routine should be, simply, another operating expense. For smaller batches particularly, one failed result here doesn’t take out an entire harvest, making it all the more crucial.
As states keep expanding what they test for, and how they re-test it, the gap between a lab’s result and a state re-test is likely to grow, meaning a passing result today won’t necessarily pass next year’s rules. Before next season’s harvest goes to the lab, every operator should know exactly who pays if that result turns out to be wrong.
Compliance Isn’t Indemnification
A state-mandated test is a license to sell, not an insurance policy against recalls. Until cannabis industry testing standards are uniformly enforced and labs share liability, operators must treat their testing and manufacturing vendors as core liabilities—tightening contracts, double-checking results, and protecting their balance sheets long before products reach the shelf to protect against the financial fallout of product recalls.
About the Author: Griffin Basden is a Senior Client Manager at AlphaRoot, an insurance brokerage dedicated to the cannabis industry, where she specializes in helping operators navigate operational risk, regulatory compliance, and supply chain liability.











